The incidence of COVID-19 has been going up since September, with November bringing records one after another, both in large cities and in Russia as a whole. Naturally, the demand for certain “corona-specific” drugs has also been increasing. With that more or less predicted, the market participants at all stages of commodity distribution, including wholesale, were preparing for an increase in morbidity associated with the end of the vacation season and the start of the school year when the labeling system altered the situation.

Between January and October 2020, the sales of veterinary drugs in the retail market amounted to RUB 17.6 bln (retail prices, VAT included), which is in monetary terms (rubles) 0.1% lower than in 2019. The volume in physical terms is 159.3 bln minimum dosage units (MDU), which is 0.9% lower than in 2019.

Between January and September 2020, Russia imported RUB 18.3 bln worth of pharmaceutical drugs for clinical trials (CT) (customs clearance and VAT included), which is in monetary terms (rubles) a bit more than 40% higher than in 2019. The dynamics in physical terms (units) are somewhat lower, +17%, with the import volume of 672,000 units.

Between January and September 2020, Russian manufacturers produced RUB 356.2 bln worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), which is in monetary terms (rubles) 20.8% higher than in 2019. The dynamics in physical terms (units) are +10.5%, with the manufacture volume of 3.5 bln units. If calculated in minimum dosage units (MDU), the dynamics are +14.2%.

Vaccines, the most important group of veterinary drugs, take up nearly 45% of the total import of veterinary products in monetary terms. Between January and September 2020, Russia imported more than RUB 10.55 bln worth of veterinary vaccines (customs clearance included), which is in monetary terms (rubles) 13.8% higher than in 2019. At the same time, the dynamics of veterinary import are only +7%.

Between January and September 2020, Russia imported RUB 1.91 bln worth of veterinary APIs (customs clearance and VAT included), which is in monetary terms (rubles) 22% lower than in 2019. In physical terms, the import volume amounts to 802 tons, with the dynamics of -26%.

The dynamics of the import of veterinary drugs in monetary terms (rubles) in September have surged to +30%, when in July and August they were -1-2%. Between January and September, Russia imported RUB 23.7 bln worth of veterinary drugs (customs clearance and VAT included), which is in monetary terms 6.5% higher than in 2019. As for feed supplements, the September dynamics are -1.2%, which is good news after -18.4% in August. The import volume for the period between January and September amounts to RUB 30.2 bln, with the dynamics of +12.4%.

Between January and September 2020, Russia imported RUB 120.2 bln worth of APIs (customs clearance and VAT included), which is in monetary terms (rubles) 22% lower than in 2019. The import volume in physical terms (tons) amounted to 10.9 thousand tons, with the dynamics of +14%.

12% of doctors note that their income has sharply decreased as a result of the coronavirus epidemic, according to a survey by the RNC Pharma analyst company and the website for Russian doctors Medvestnik. The reasons may be different, in particular, forced vacation, dismissal, etc. Another 37% of the respondents say that their earnings have just “significantly decreased.” Finally, another 6% say that while their income has grown, it is disproportionate to the increase in the workload, which is, in this case, still as a salary reduction. In total, 55% of the respondents have faced a decrease in income.

Between January and September 2020, Russia imported RUB 359.3 bln worth of ready-made pharmaceutical drugs (customs clearance and VAT included), which is in monetary terms (rubles) 22% lower than in 2019. The dynamics of the in-bulk import are +9%.